SCHEMBL14339077

SCHEMBL14339077

CCOc1cccc2[nH]c(C)c(C(=O)C(N)=O)c12

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GRK6 P43250 1/20 0.48
▸ PLA2G2A P14555 11/20 0.46
▸ PLA2G1B P04054 5/20 0.43
▸ PLA2G10 O15496 2/20 0.42
▸ PLA2G5 P39877 2/20 0.42
▸ PLA2G2E Q9NZK7 1/20 0.42
▸ CDK1 P06493 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ MAPT P10636 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ PABPC1 P11940 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13485088 0.87 PLA2G2A (0.56) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL13484713 0.82 PLA2G2A (0.42) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL14531285 0.82 PLA2G2A (0.47) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL13597693 0.81 MAPT (0.42) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL14514453 0.78 PLA2G2A (0.46) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL14530080 0.77 PLA2G2A (0.46) PLA2G2AMAPTPOLBALDH1A1MEN1
SCHEMBL13485122 0.77 PLA2G2A (0.41) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL4758276 0.73 PLA2G2A (0.45) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL6009625 0.73 GRK6 (0.54) GRK6CDK1CDK2MAPTPOLB
SCHEMBL28108507 0.73 SLC2A1 (0.47) PLA2G2APLA2G1BMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070292385-A1 Phospholipase Inhibitors Localized in the Gastrointestinal Lumen ILYPSA, INC. 2007-12-20 — — US disclosed
US-20070135383-A1 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors ILYPSA, INC. 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135383-A1 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors PNLIP, PLA2G2E, PLA2G3 GRK6 2733/4885PLA2G2A 13/4885PLA2G1B 10/4885
US-20070292385-A1 Phospholipase Inhibitors Localized in the Gastrointestinal Lumen PNLIP, PLA2G2E, PLA2G4B GRK6 2063/4885PLA2G2A 7/4885PLA2G1B 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback